Clarify the Role of Ongentys and Kynmobi for Parkinson's Disease

December 2020

Ongentys (opicapone) and Kynmobi (apomorphine) will add to the growing list of new meds for Parkinson's disease.

They're for "off" episodes...when symptoms (tremor, etc) return between carbidopa/levodopa doses, especially as Parkinson's progresses.

Recommend optimizing carbidopa/levodopa first...such as with more frequent dosing. Put the role of the new meds in perspective.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Diabetes Meds Expect to See SGLT2 Inhibitors for Some Patients WithOUT Diabetes
Pregnancy Educate Pregnant Moms About Treating Pain or Fever
Alcohol Listen for Questions About Hangover Remedies
Venous Thromboembolism Be Prepared With Answers About Treating VTE
Contraceptives Watch for Twirla, a New Contraceptive Patch
Benzodiazepines Consider Strategies for Safe Use of Benzodiazepines
Parkinson's Disease Clarify the Role of Ongentys and Kynmobi for Parkinson's Disease
Vaccines Ensure Patients Get Recommended Meningococcal Vaccines
Practice Help Patients Navigate Mobile Health Apps
Infectious Diseases Understand Roles of Remdesivir and Dexamethasone for COVID-19
Immunizations Expect More Pharmacy Technicians to Give Vaccines